← Medication Database
Other Specialties

Pavblu

Generic: aflibercept-ayyh

Manufacturer: Amgen  ·  Program:

Apply for Assistance

Eligibility Criteria

Insurance Requirement

See program details

Residency

US residency required

Income Threshold

Up to 500% FPL

Individual Income Limit

$72,900/year

Program Information

Processing Time

1–2 weeks

Delivery Method

shipped to patient

Application Method

Multiple

Indicated For

Wet AMD, RVO, DME, DR

About This Medication

# Pavblu (aflibercept-ayyh) Patient Guide: How to Get Pavblu at Low or No Cost Pavblu (aflibercept-ayyh) is an injectable medication manufactured by Amgen, typically used to treat certain eye conditions by blocking abnormal blood vessel growth in the retina. Amgen's primary patient assistance program, **Amgen Safety Net Foundation**, provides qualifying patients with free medication if they meet specific eligibility criteria, primarily targeting uninsured or underinsured U.S. residents with low household income.[4][6] ## Who Qualifies for Amgen Safety Net Foundation? Eligibility focuses on residency, insurance status, and income. Key requirements include: - Living in the U.S. or a U.S. territory for at least six months.[4] - Being uninsured, or having insurance that doesn't cover Pavblu (limited assistance may be available for some Medicare Part D patients).[4] - Household income below limits based on federal poverty guidelines (FPL); exact percentages are not publicly specified but are typically around 400-500% FPL for similar programs—confirm current thresholds during application.[4] **Amgen SupportPlus** offers additional resources like copay assistance for commercially insured patients, insurance verification, and reimbursement support, but free medication comes through the Safety Net Foundation.[1][2][5] ## About Pavblu (aflibercept-ayyh) Pavblu is a biosimilar to Eylea, administered as an intravitreal injection by a healthcare provider to treat conditions like wet age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion (RVO). It works by inhibiting vascular endothelial growth factor (VEGF), reducing leakage and vision loss. As an Amgen product, it's supported through Amgen's access programs. Always consult your doctor for personalized advice on its use, side effects (e.g., eye inflammation, increased intraocular pressure), or interactions.[1][2] ## Income Eligibility Breakdown Specific income thresholds for Pavblu are not detailed publicly and vary by household size and current FPL. Programs like Amgen Safety Net base limits on federal poverty guidelines, often up to 400-600% FPL. Use the table below as a general guide (based on 2026 FPL estimates; verify with Amgen for exacts): | Household Size | Estimated Max Income (400% FPL) | Estimated Max Income (500% FPL) | |----------------|--------------------------------|--------------------------------| | 1 (Individual) | $60,000 | $75,000 | | 2 (Couple) | $81,000 | $101,250 | | 3 | $102,000 | $127,500 | | 4 | $123,000 | $153,750 | *Notes: Add ~$21,000 per additional person for 400% FPL. Exact limits confirmed during application. Medicare patients may have restrictions.[4] ## Insurance Requirements - **Uninsured or underinsured**: Primary eligibility for free drug via Safety Net Foundation.[4] - **Commercial insurance**: May qualify for copay cards or SupportPlus reimbursement help.[1][3] - **Medicare/Medicaid**: Limited or no eligibility for free drug; some Part D patients may get help if not covered. No reimbursement from government programs allowed for Foundation meds.[4][6] Contact Amgen SupportPlus to verify benefits before applying.[2][5] ## Step-by-Step Application Process 1. **Check eligibility**: Review income, residency, and insurance via amgensupportplus.com or call 1-800-77-AMGEN (1-800-772-6436).[1][2] 2. **Gather documents**: Prescription, proof of income (tax returns, pay stubs), proof of residency, insurance details (if any).[6] 3. **Apply**: Use Amgen Safety Net Foundation application—download forms from myamgenportal.com or HCP sites, or apply via partners like Simplefill (877-386-0206) for no-paperwork help.[4][5][6] 4. **Submit**: Fax forms (e.g., Insurance Verification to SupportPlus) or mail to Foundation. Patient certifies info accuracy and no insurance reimbursement.[5][6] 5. **Follow up**: Expect verification call. HCP may assist with forms.[1] For copay programs (commercial insurance), enroll online or call product-specific lines like 1-844-REPATHA model.[3] ## Timeline and Delivery Processing time varies (typically 2-4 weeks), with patient certification required within 30 days of changes.[6] Approved meds ship directly to your doctor's office or pharmacy for injection—no home delivery specified. Refills require reauthorization; notify of insurance/income changes within 30 days.[6] ## Alternatives if Denied - **Copay assistance**: If commercially insured, use SupportPlus copay cards (e.g., max savings apply).[1][3] - **Other foundations**: Simplefill matches to 1,000+ programs.[4] - **State programs**: Check Medicaid, pharmaceutical copay funds, or 340B clinics. - **Biosimilars**: None listed for Pavblu; discuss alternatives like Eylea with your doctor. - **Reapply**: Fix issues (e.g., income proof) and resubmit. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change—always verify directly with Amgen SupportPlus (amgensupportplus.com, 1-800-772-6436) or your healthcare provider. Not medical advice; consult professionals for health decisions. Program maximums and criteria apply; patient must not seek insurance/government reimbursement for free meds.[1][2][4][6]

Program information last verified: March 30, 2026

Ready to apply for Pavblu assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications